Abbott Laboratories vs. Arcturus Therapeutics Holdings Inc. Common Stock
ABT
Abbott Laboratories
$110.08 -2.13%
VS ARCTArcturus Therapeutics Holdings Inc. Common Stock
$14.46 -4.77%
Abbott Laboratories (ABT) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ABT | ARCT | |
|---|---|---|
| Market Cap | $194.62 billion | $431.75 million |
| Revenue (TTM) | $46.59 billion | $29.37 million |
| Net Income (TTM) | $5.42 billion | $-93,276,000 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | ARCT | |
|---|---|---|
| P/E Ratio | 35.62 | — |
| Price / Book | 3.76 | 2.51 |
| Price / Sales | 4.18 | 14.70 |
ABT and ARCT split the valuation factors evenly.
Profitability
| ABT | ARCT | |
|---|---|---|
| Net Margin | 11.65% | -317.62% |
| Return on Equity | 10.48% | -54.29% |
ABT leads on 2 of 2 profitability factors.
Dividend
| ABT | ARCT | |
|---|---|---|
| Dividend Yield | 2.29% | — |
| Payout Ratio | 81.55 | — |
ABT and ARCT split the dividend factors evenly.
Risk & Sentiment
| ABT | ARCT | |
|---|---|---|
| Short Interest | 0.57% | 0.22% |
ARCT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, ARCT overview, ARCT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.